Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SinoFresh Laboratories, Inc. was a pharmaceutical company focused on the research, development, and marketing of therapies to treat inflammatory and infectious diseases of the upper respiratory system. The company's primary product was SinoFresh Nasal & Sinus Care, an over-the-counter nasal spray formulated with cetylpyridinium chloride (CPC) to provide symptomatic relief for chronic sinusitis and other sinus-related conditions. In November 2002, SinoFresh Laboratories' assets were acquired by SinoFresh HealthCare, Inc., which subsequently expanded the distribution of the product nationally. The product was designed to kill bacteria and viruses, including MRSA and H1N1, on contact through physical disruption of cell walls.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SinoFresh Laboratories.